These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7525865)

  • 1. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.
    Ward KN; Dhaliwal W; Ashworth KL; Clutterbuck EJ; Teo CG
    J Med Virol; 1994 Aug; 43(4):367-72. PubMed ID: 7525865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
    Kanno A; Kazuyama Y
    J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.
    Patel EU; Cox AL; Mehta SH; Boon D; Mullis CE; Astemborski J; Osburn WO; Quinn J; Redd AD; Kirk GD; Thomas DL; Quinn TC; Laeyendecker O
    J Infect Dis; 2016 Aug; 214(3):344-52. PubMed ID: 26768250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of low-avidity IgG antibodies in the diagnosis of primary acute infection by hepatitis C virus].
    León P; López JA; de Ory F; Elola C; Echevarría JM
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):14-8. PubMed ID: 9147501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.
    Gaudy-Graffin C; Lesage G; Kousignian I; Laperche S; Girault A; Dubois F; Goudeau A; Barin F
    J Clin Microbiol; 2010 Sep; 48(9):3281-7. PubMed ID: 20610669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype.
    Shepherd SJ; McDonald SA; Palmateer NE; Gunson RN; Aitken C; Dore GJ; Goldberg DJ; Applegate TL; Lloyd AR; Hajarizadeh B; Grebely J; Hutchinson SJ
    J Med Virol; 2018 Jan; 90(1):120-130. PubMed ID: 28843002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots.
    Eshetu A; Hauser A; An der Heiden M; Schmidt D; Meixenberger K; Ross S; Obermeier M; Ehret R; Bock CT; Bartmeyer B; Bremer V; Bannert N
    J Immunol Methods; 2020 Apr; 479():112744. PubMed ID: 31958450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to recombinant and synthetic peptides derived from the hepatitis C virus genome in long-term-studied patients with posttransfusion hepatitis C.
    Mattsson L; Gutierrez RA; Dawson GJ; Lesniewski RR; Mushahwar LK; Weiland O
    Scand J Gastroenterol; 1991 Dec; 26(12):1257-62. PubMed ID: 1722348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of HCV infection stage in a group of seropositive patients from Maracaibo, Venezuela by measurement the antibody avidity index of anti-HCV IgG].
    Cuadra Sánchez CA; Porto-Espinoza LD; Callejas-Monsalve DE; Moronta-Piñango RM; Mindiola-Morles RC; Atencio-Tello RJ
    Rev Gastroenterol Peru; 2007; 27(4):361-6. PubMed ID: 18183277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection.
    Sagnelli E; Tonziello G; Pisaturo M; Sagnelli C; Coppola N
    Antivir Ther; 2012; 17(7 Pt B):1453-8. PubMed ID: 23322703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index.
    Coppola N; Pisapia R; Tonziello G; Masiello A; Martini S; Pisaturo M; Messina V; Sagnelli C; Macera M; Signoriello G; Sagnelli E
    J Clin Virol; 2009 Nov; 46(3):222-9. PubMed ID: 19758839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.
    Klimashevskaya S; Obriadina A; Ulanova T; Bochkova G; Burkov A; Araujo A; Stramer SL; Tobler LH; Busch MP; Fields HA
    J Clin Microbiol; 2007 Oct; 45(10):3400-3. PubMed ID: 17715377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of IgM response in hepatitis C virus infection.
    Zaaijer HL; Mimms LT; Cuypers HT; Reesink HW; van der Poel CL; Taskar S; Lelie PN
    J Med Virol; 1993 Jul; 40(3):184-7. PubMed ID: 7689091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots.
    Shepherd SJ; Kean J; Hutchinson SJ; Cameron SO; Goldberg DJ; Carman WF; Gunson RN; Aitken C
    J Clin Virol; 2013 May; 57(1):29-35. PubMed ID: 23369886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
    Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
    J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HCV immunoglobulin M antibody in patients with hepatitis C.
    Kikuchi T; Onji M; Michitaka K; Saito I; Miyamura T; Ohta Y
    J Gastroenterol Hepatol; 1992; 7(3):246-8. PubMed ID: 1319222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low temperature dependent IgG3 subclass antibody with low avidity to C100-3 antigen derived from hepatitis C virus in voluntary blood donors.
    Suzuki Y; Matsumoto C; Watanabe J; Yahagi N; Nishioka K
    Jpn J Med Sci Biol; 1993 Apr; 46(2):57-74. PubMed ID: 8271476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees.
    Beach MJ; Meeks EL; Mimms LT; Vallari D; DuCharme L; Spelbring J; Taskar S; Schleicher JB; Krawczynski K; Bradley DW
    J Med Virol; 1992 Mar; 36(3):226-37. PubMed ID: 1373438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of low-avidity specific IgG antibody in the diagnosis of hepatitis C virus acute primary infection].
    Echevarría JM; Avellón A
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):706-7. PubMed ID: 21684043
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein.
    Zhang ZX; Chen M; Wallhagen K; Trojnar J; Magnius LO; Wahren B; Sällberg M
    Clin Exp Immunol; 1994 Jun; 96(3):403-9. PubMed ID: 7516270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.